These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Stage II (N1) lung cancer.
    Author: Choy O, Jahan T, Roach M, You L, Jablons D.
    Journal: Chest Surg Clin N Am; 2001 Feb; 11(1):39-59, viii. PubMed ID: 11253600.
    Abstract:
    As therapies evolve and mature, the authors predict that the next 20 years will see significant advances in the understanding of non-small-cell lung cancer (NSCLC), in molecular stratification of NSCLC, and significant improvement in survival and cure rates. This survival will be achieved through early detection and combined treatments using effective surgical interventions, improved radiotherapeutics, and especially significantly enhanced, rationally designed systemic therapies.
    [Abstract] [Full Text] [Related] [New Search]